Australian Scientists Identify Enzyme With Role In Heart Attack Damage
This article was originally published in PharmAsia News
Executive SummaryAustralian researchers report that a nasal enzyme has a role in causing damage during a heart attack. Working at the ARC Centre of Excellence for Free Radical Chemistry and Biotechnology, the scientists said the acid-containing enzyme is automatically dumped onto bacteria after white cells detect their presence. The enzyme in turn produces an acidic bleach, also used as a common way to get rid of bacteria. Under inflammatory conditions such as heart attack, however, the enzyme is dumped in the wrong place. Scientists also have identified antioxidant nitroxides effective in preventing the enzyme from producing its acid. (Click here for more
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.